Explore more publications!
Latin American Newswire
Got News to Share?

Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 3, 2026

Banco Itaú Chile Reschedules Fourth Quarter 2025 Financial Results Conference Call
Feb. 3, 2026

Banco Itaú Chile Reschedules Fourth Quarter 2025 Financial Results Conference Call

Indeterminate GlobeNewswire
TIAN RUIXIANG Announces Groundbreaking USD1.5 billion plan to acquire 15,000 BTC from a Strategic Investor, Unveiling Deep AI and Cryptocurrency Synergy Partnership
Feb. 3, 2026

TIAN RUIXIANG Announces Groundbreaking USD1.5 billion plan to acquire 15,000 BTC from a Strategic Investor, Unveiling Deep AI and Cryptocurrency Synergy Partnership

Indeterminate GlobeNewswire
Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion
Feb. 3, 2026

Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion

Indeterminate GlobeNewswire
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
Feb. 3, 2026

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Indeterminate GlobeNewswire
Ardelyx Receives New Patent for Tenapanor
Feb. 3, 2026

Ardelyx Receives New Patent for Tenapanor

Indeterminate GlobeNewswire
Beghou Names Meredith Ressi as President and Chief Growth Officer
Feb. 3, 2026

Beghou Names Meredith Ressi as President and Chief Growth Officer

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 3, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Highland Copper to Present at Upcoming Events
Feb. 3, 2026

Highland Copper to Present at Upcoming Events

Indeterminate GlobeNewswire
HPQ Silicon Increases Equity Stake in Novacium SAS, Strengthening Global Exposure and Short and Medium-Term Value Creation
Feb. 3, 2026

HPQ Silicon Increases Equity Stake in Novacium SAS, Strengthening Global Exposure and Short and Medium-Term Value Creation

Indeterminate GlobeNewswire
NCRF’s 10th Annual HBCU Caravan Features College Expos, HBCU Expos and High School Visits Throughout California
Feb. 3, 2026

NCRF’s 10th Annual HBCU Caravan Features College Expos, HBCU Expos and High School Visits Throughout California

Indeterminate EIN Presswire
1inch Survey Reports 72% of DeFi Users Express Positive Sentiment
Feb. 3, 2026

1inch Survey Reports 72% of DeFi Users Express Positive Sentiment

Indeterminate GlobeNewswire
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
Feb. 3, 2026

Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration

Indeterminate GlobeNewswire
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Feb. 3, 2026

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

Indeterminate GlobeNewswire
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer
Feb. 3, 2026

Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

Indeterminate GlobeNewswire
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Feb. 3, 2026

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Indeterminate GlobeNewswire
Brunswick Exploration Acquires More Highly Prospective Lithium Targets in Greenland
Feb. 3, 2026

Brunswick Exploration Acquires More Highly Prospective Lithium Targets in Greenland

Indeterminate GlobeNewswire
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
Feb. 3, 2026

Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity

Indeterminate GlobeNewswire
Patria Reports Fourth Quarter & Full Year 2025 Earnings Results
Feb. 3, 2026

Patria Reports Fourth Quarter & Full Year 2025 Earnings Results

Indeterminate GlobeNewswire
Banco de Bogotá S.A. Announces Early Tender Results of Cash Tender Offer for up to U.S.$500,000,000 Aggregate Principal Amount of the Outstanding U.S.$1,082,500,000 Aggregate Principal Amount of 6.250% Subordinated Notes Due 2026 (CUSIP Nos. 059514 AC3…
Feb. 3, 2026

Banco de Bogotá S.A. Announces Early Tender Results of Cash Tender Offer for up to U.S.$500,000,000 Aggregate Principal Amount of the Outstanding U.S.$1,082,500,000 Aggregate Principal Amount of 6.250% Subordinated Notes Due 2026 (CUSIP Nos. 059514 AC3…

Indeterminate GlobeNewswire
M EVO GLOBAL ACQUISITION CORP II Announces Closing of $300 Million Initial Public Offering
Feb. 3, 2026

M EVO GLOBAL ACQUISITION CORP II Announces Closing of $300 Million Initial Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions